2007
2006
2005
2004
2003
2002
2001
2000
1999
1998
1997
1996
1995
1994




    

Company Abstracts  ::  2005

2005 Presentation Abstracts
 

2005 Publications Abstracts


SMALL MOLECULE INHIBITORS OF SSAO /AOC3 AS THERAPEUTICS FOR INFLAMMATORY AND AUTOIMMUNE DISORDERS
A. M. O’Rourke, et al
Presented at the
ACR/ARHP Scientific Meeting, San Diego, CA
November 14, 2005


PROGRESSIVE REDUCTION IN RISK OF RENAL FLARE IN SLE PATIENTS IS ASSOCIATED WITH IMPROVED LONG-TERM CONTROL OF ANTI-DSDNA ANTIBODY LEVELS
Matthew D. Linnik, et al
Presented at the
ACR/ARHP Annual Scientific Meeting
November 13-17, 2005



DOMAIN V OF BETA2-GLYCOPROTEIN I BINDS FACTOR XI/XIa AND IS CLEAVED AT Lys317-Thr318
T. Shi, et al.
Published in
Journal of Biological Chemistry
2005
Volume 280: pp. 907-912


ABETIMUS SODIUM: A NEW THERAPY FOR DELAYING THE TIME TO, AND REDUCING THE INCIDENCE OF, RENAL FLARE AND/OR MAJOR SYSTEMIC LUPUS ERYTHEMATOSUS FLARES IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS WHO HAVE A HISTORY OF RENAL DISEASE
Mario H Cardiel
Published in
Expert Opin Investig Drugs
2005
Volume 14, Issue 1: pp. 77-88


RELATIONSHIP BETWEEN ANTI-DOUBLE-STRANDED DNA ANTIBODIES AND EXACERBATION OF RENAL DISEASE IN PATIENTS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
M. Linnik, et al.
Published in
Arthritis & Rheumatism
April 2005
Volume 52, No. 4, pp1129-1137


ANTI-INFLAMMATORY EFFECTS OF INHIBITING THE AMINE OXIDASE ACTIVITY OF SEMICARBAZIDE-SENSITIVE AMINE OXIDASE
LM Salter-Cid, et al
Published in
Journal of Pharmacology and Experimental Therapeutics
Nov. 2005
Volume 315, No. 2 pp 553-562






Terms of Use & Privacy Policy
Copyright © 2008, La Jolla Pharmaceutical Company